IGF1 and metabolic dysfunction-associated steatotic liver disease: Dysregulation of the IGF system contributes to the progression of multiple chronic liver diseases, such as nonalcoholic fatty liver disease (NAFLD), which may gradually promote hepatocarcinogenesis [19].